A detailed history of Essex Investment Management CO LLC transactions in Novartis Ag stock. As of the latest transaction made, Essex Investment Management CO LLC holds 2,775 shares of NVS stock, worth $268,564. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,775
Previous 3,625 23.45%
Holding current value
$268,564
Previous $385,000 17.14%
% of portfolio
0.06%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$106.13 - $120.89 $90,210 - $102,756
-850 Reduced 23.45%
2,775 $319,000
Q3 2023

Nov 09, 2023

SELL
$94.73 - $105.13 $21,598 - $23,969
-228 Reduced 5.92%
3,625 $369,000
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $15,728 - $17,834
-170 Reduced 4.23%
3,853 $388,000
Q4 2022

Feb 02, 2023

SELL
$75.55 - $92.52 $5,892 - $7,216
-78 Reduced 1.9%
4,023 $365,000
Q2 2021

Aug 12, 2021

SELL
$85.24 - $94.15 $104,419 - $115,333
-1,225 Reduced 23.0%
4,101 $374,000
Q4 2020

Feb 12, 2021

SELL
$78.07 - $94.43 $5,855 - $7,082
-75 Reduced 1.39%
5,326 $503,000
Q3 2020

Nov 12, 2020

SELL
$82.14 - $91.0 $12,238 - $13,559
-149 Reduced 2.68%
5,401 $470,000
Q1 2020

May 04, 2020

SELL
$70.67 - $99.01 $99,503 - $139,406
-1,408 Reduced 20.24%
5,550 $458,000
Q3 2019

Oct 22, 2019

SELL
$85.54 - $94.26 $184,424 - $203,224
-2,156 Reduced 23.66%
6,958 $605,000
Q1 2019

May 15, 2019

SELL
$75.32 - $86.15 $485,964 - $555,839
-6,452 Reduced 41.45%
9,114 $876,000
Q4 2018

Feb 06, 2019

BUY
$73.66 - $82.02 $488,071 - $543,464
6,626 Added 74.12%
15,566 $1.34 Million
Q3 2018

Oct 16, 2018

SELL
$66.94 - $77.43 $8,568 - $9,911
-128 Reduced 1.41%
8,940 $770,000
Q1 2018

Apr 26, 2018

BUY
$70.39 - $84.15 $4,153 - $4,964
59 Added 0.65%
9,068 $733,000
Q3 2017

Oct 30, 2017

BUY
$74.14 - $77.27 $667,927 - $696,125
9,009
9,009 $773,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $208B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.